C-Rad AB (publ) (CRAD-B.ST)
SEK 29.9
(-0.17%)
SEK 29.9
(-0.17%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 44.24 Million SEK | 185.87% |
| 2022 | 21.75 Million SEK | -39.55% |
| 2021 | 35.99 Million SEK | 110.69% |
| 2020 | 17.08 Million SEK | 293.74% |
| 2019 | -8.81 Million SEK | -1191.34% |
| 2018 | 808 Thousand SEK | 108.09% |
| 2017 | -9.99 Million SEK | 67.09% |
| 2016 | -30.35 Million SEK | -48.72% |
| 2015 | -20.41 Million SEK | -56.95% |
| 2014 | -13 Million SEK | 35.99% |
| 2013 | -20.31 Million SEK | -6.66% |
| 2012 | -19.04 Million SEK | 54.76% |
| 2011 | -42.1 Million SEK | -346.97% |
| 2010 | -9.41 Million SEK | 5.08% |
| 2009 | -9.92 Million SEK | 6.62% |
| 2008 | -10.62 Million SEK | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 19.1 Million SEK | 60.5% |
| 2024 Q3 | 17.4 Million SEK | -5.24% |
| 2024 Q1 | 11.9 Million SEK | -60.07% |
| 2023 Q1 | 6.3 Million SEK | 0.67% |
| 2023 FY | 62.2 Million SEK | 185.87% |
| 2023 Q4 | 29.8 Million SEK | 56.84% |
| 2023 Q2 | 7.5 Million SEK | 19.05% |
| 2023 Q3 | 19 Million SEK | 153.33% |
| 2022 Q3 | 14.6 Million SEK | 1725.0% |
| 2022 Q1 | 200 Thousand SEK | -98.66% |
| 2022 Q2 | 800 Thousand SEK | 300.0% |
| 2022 FY | 21.75 Million SEK | -39.55% |
| 2022 Q4 | 6.25 Million SEK | -57.14% |
| 2021 Q3 | 8.8 Million SEK | 46.67% |
| 2021 FY | 35.99 Million SEK | 110.69% |
| 2021 Q2 | 6 Million SEK | -3.23% |
| 2021 Q1 | 6.2 Million SEK | -36.63% |
| 2021 Q4 | 14.89 Million SEK | 69.26% |
| 2020 FY | 17.08 Million SEK | 293.74% |
| 2020 Q3 | 5.4 Million SEK | 500.0% |
| 2020 Q2 | 900 Thousand SEK | -10.0% |
| 2020 Q1 | 1 Million SEK | 108.31% |
| 2020 Q4 | 9.78 Million SEK | 81.19% |
| 2019 Q1 | -26.8 Million SEK | -935.41% |
| 2019 Q2 | -600 Thousand SEK | 97.76% |
| 2019 Q3 | 1.7 Million SEK | 383.33% |
| 2019 FY | -8.81 Million SEK | -1191.34% |
| 2019 Q4 | -12.03 Million SEK | -807.76% |
| 2018 Q4 | 3.2 Million SEK | 702.0% |
| 2018 Q2 | 2 Million SEK | 142.55% |
| 2018 FY | 808 Thousand SEK | 108.09% |
| 2018 Q1 | -4.7 Million SEK | -326.18% |
| 2018 Q3 | 400 Thousand SEK | -80.0% |
| 2017 Q3 | -1.3 Million SEK | 68.29% |
| 2017 Q1 | -5.66 Million SEK | -27.44% |
| 2017 FY | -9.99 Million SEK | 67.09% |
| 2017 Q4 | 2.07 Million SEK | 259.85% |
| 2017 Q2 | -4.1 Million SEK | 27.63% |
| 2016 Q3 | -7.9 Million SEK | 19.23% |
| 2016 Q4 | -4.44 Million SEK | 43.75% |
| 2016 FY | -30.35 Million SEK | -48.72% |
| 2016 Q1 | -8.22 Million SEK | -34.34% |
| 2016 Q2 | -9.78 Million SEK | -18.96% |
| 2015 Q1 | -1.17 Million SEK | 75.23% |
| 2015 FY | -20.41 Million SEK | -56.95% |
| 2015 Q4 | -6.12 Million SEK | 12.12% |
| 2015 Q3 | -6.96 Million SEK | -13.24% |
| 2015 Q2 | -6.15 Million SEK | -425.06% |
| 2014 Q1 | -1.58 Million SEK | 41.32% |
| 2014 Q3 | -2.67 Million SEK | 38.92% |
| 2014 FY | -13 Million SEK | 35.99% |
| 2014 Q4 | -4.73 Million SEK | -76.84% |
| 2014 Q2 | -4.37 Million SEK | -176.23% |
| 2013 FY | -20.31 Million SEK | -6.66% |
| 2013 Q1 | -5.82 Million SEK | -294.68% |
| 2013 Q2 | -9.95 Million SEK | -70.93% |
| 2013 Q3 | -1.84 Million SEK | 81.49% |
| 2013 Q4 | -2.7 Million SEK | -46.66% |
| 2012 Q1 | -7.03 Million SEK | 71.59% |
| 2012 FY | -19.04 Million SEK | 54.76% |
| 2012 Q4 | -1.47 Million SEK | 71.25% |
| 2012 Q3 | -5.13 Million SEK | 5.05% |
| 2012 Q2 | -5.4 Million SEK | 23.19% |
| 2011 Q1 | -5.03 Million SEK | -38.15% |
| 2011 Q4 | -24.76 Million SEK | -552.47% |
| 2011 Q2 | -8.5 Million SEK | -68.74% |
| 2011 Q3 | -3.79 Million SEK | 55.35% |
| 2011 FY | -42.1 Million SEK | -346.97% |
| 2010 Q2 | -3.67 Million SEK | -151.5% |
| 2010 Q3 | -635 Thousand SEK | 82.73% |
| 2010 Q1 | -1.46 Million SEK | -29.02% |
| 2010 FY | -9.41 Million SEK | 5.08% |
| 2010 Q4 | -3.64 Million SEK | -474.29% |
| 2009 Q3 | -3.5 Million SEK | -22.79% |
| 2009 Q2 | -2.85 Million SEK | -17.77% |
| 2009 Q1 | -2.42 Million SEK | 38.69% |
| 2009 FY | -9.92 Million SEK | 6.62% |
| 2009 Q4 | -1.13 Million SEK | 67.7% |
| 2008 FY | -10.62 Million SEK | 0.0% |
| 2008 Q2 | -1.74 Million SEK | 29.96% |
| 2008 Q1 | -2.49 Million SEK | 0.0% |
| 2008 Q3 | -2.54 Million SEK | -45.65% |
| 2008 Q4 | -3.95 Million SEK | -55.59% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acarix AB (publ) | -77.55 Million SEK | 157.05% |
| ADDvise Group AB (publ) | 300.6 Million SEK | 85.281% |
| ADDvise Group AB (publ) | 300.6 Million SEK | 85.281% |
| Arcoma AB | 4.66 Million SEK | -849.442% |
| Bactiguard Holding AB (publ) | -131.93 Million SEK | 133.535% |
| BICO Group AB (publ) | -618.3 Million SEK | 107.156% |
| Boule Diagnostics AB (publ) | 39.27 Million SEK | -12.666% |
| CellaVision AB (publ) | 167.05 Million SEK | 73.515% |
| Clinical Laserthermia Systems AB (publ) | -65.93 Million SEK | 167.104% |
| Chordate Medical Holding AB (publ) | -29.57 Million SEK | 249.617% |
| Duearity AB (publ) | -25.76 Million SEK | 271.735% |
| Dignitana AB (publ) | -15.02 Million SEK | 394.45% |
| Episurf Medical AB (publ) | -94.8 Million SEK | 146.671% |
| Getinge AB (publ) | 3.81 Billion SEK | 98.84% |
| Scandinavian Real Heart AB (Publ) | -68.44 Million SEK | 164.641% |
| Iconovo AB (publ) | -45.77 Million SEK | 196.652% |
| Integrum AB (publ) | 6.51 Million SEK | -579.387% |
| Luxbright AB (publ) | -25.8 Million SEK | 271.459% |
| Mentice AB (publ) | -679 Thousand SEK | 6616.053% |
| OssDsign AB (publ) | -91.95 Million SEK | 148.114% |
| Paxman AB (publ) | 12.61 Million SEK | -250.614% |
| Promimic AB (publ) | -9.11 Million SEK | 585.238% |
| Qlife Holding AB (publ) | -168.69 Million SEK | 126.227% |
| SciBase Holding AB (publ) | -53.93 Million SEK | 182.026% |
| ScandiDos AB (publ) | -13.48 Million SEK | 428.147% |
| Sectra AB (publ) | 518.49 Million SEK | 91.467% |
| Sedana Medical AB (publ) | -65.54 Million SEK | 167.5% |
| Senzime AB (publ) | -133.74 Million SEK | 133.081% |
| SpectraCure AB (publ) | -21.35 Million SEK | 307.222% |
| Stille AB | 44.95 Million SEK | 1.575% |
| Vitrolife AB (publ) | -3.58 Billion SEK | 101.233% |
| Xvivo Perfusion AB (publ) | 38.5 Million SEK | -14.902% |